acetylleucyl-leucyl-norleucinal has been researched along with glucose, (beta-d)-isomer in 1 studies
Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (glucose, (beta-d)-isomer) | Trials (glucose, (beta-d)-isomer) | Recent Studies (post-2010) (glucose, (beta-d)-isomer) |
---|---|---|---|---|---|
321 | 0 | 53 | 21,956 | 883 | 10,747 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Genth, H; Gerhard, R; Just, I; Nottrott, S; Schoentaube, J | 1 |
1 other study(ies) available for acetylleucyl-leucyl-norleucinal and glucose, (beta-d)-isomer
Article | Year |
---|---|
Clostridium difficile toxin A-induced apoptosis is p53-independent but depends on glucosylation of Rho GTPases.
Topics: Actins; Apoptosis; Bacterial Toxins; Caspases; Cathepsins; Cell Cycle; Enterotoxins; Enzyme Activation; Glucosides; Glycosyltransferases; HT29 Cells; Humans; Leupeptins; Models, Biological; Protein Processing, Post-Translational; rho GTP-Binding Proteins; Tumor Suppressor Protein p53 | 2007 |